Natural Compound from Tree Extract Extends Lifespan and Fights Inflammation
Cycloneolitsol from Taxodium trees prolonged worm lifespan by 20% while reducing inflammatory markers through key cellular pathways.
Summary
Scientists discovered that cycloneolitsol, a natural compound from Taxodium trees, significantly extends lifespan in laboratory worms while reducing inflammation. The compound works through two key pathways: it activates cellular cleanup processes and antioxidant defenses via the SEK-1/PMK-1/SKN-1 pathway, while simultaneously blocking inflammatory responses through the NF-κB pathway. In studies using C. elegans worms, cycloneolitsol improved overall health markers and extended lifespan without causing reproductive harm. The compound also prevented inflammatory cell activation in laboratory tests, suggesting potential benefits for age-related inflammatory diseases in humans.
Detailed Summary
Chronic low-grade inflammation, termed 'inflammaging,' drives many age-related diseases and accelerates aging itself. This study investigated cycloneolitsol, a triterpene compound extracted from Taxodium ascendens trees, for its potential anti-aging and anti-inflammatory properties.
Researchers used two experimental models: RAW264.7 macrophage cells to test anti-inflammatory effects, and Caenorhabditis elegans worms to evaluate longevity benefits. They employed network pharmacology to predict molecular targets and tested various mutant worm strains to identify specific pathways involved.
Cycloneolitsol demonstrated significant anti-inflammatory activity by blocking NF-κB signaling in immune cells, preventing their activation into pro-inflammatory states. In worms, the compound extended lifespan and improved biological characteristics without reproductive toxicity. Mechanistic studies revealed cycloneolitsol activates the SEK-1/PMK-1/SKN-1 pathway, enhancing autophagy (cellular cleanup) and antioxidant defenses. Nuclear translocation experiments confirmed increased SKN-1 activity, a key longevity regulator.
These findings suggest cycloneolitsol addresses aging through dual mechanisms: reducing harmful inflammation while boosting cellular maintenance systems. The compound's ability to simultaneously target inflammation and activate longevity pathways makes it particularly promising for age-related disease prevention.
While these results are encouraging, the research was conducted in cell cultures and simple organisms. Human studies are needed to determine optimal dosing, safety profiles, and clinical effectiveness before considering cycloneolitsol as a therapeutic intervention for aging or inflammatory conditions.
Key Findings
- Cycloneolitsol extended C. elegans lifespan through SEK-1/PMK-1/SKN-1 pathway activation
- Compound blocked inflammatory NF-κB signaling in immune cells
- Enhanced autophagy and antioxidant stress response without reproductive toxicity
- Prevented M1-type inflammatory polarization in macrophage cells
- Increased nuclear translocation of SKN-1 longevity regulator
Methodology
Researchers used network pharmacology predictions, RAW264.7 macrophage cell cultures for inflammation testing, and multiple C. elegans mutant strains for lifespan studies. Nuclear translocation assays confirmed SKN-1 pathway activation.
Study Limitations
Studies were conducted only in cell cultures and simple worms, not mammals or humans. Optimal dosing, long-term safety, and bioavailability in humans remain unknown.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.